{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T05:07:15Z","timestamp":1776056835435,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T00:00:00Z","timestamp":1351123200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.1007\/s00125-012-2759-y","type":"journal-article","created":{"date-parts":[[2012,10,24]],"date-time":"2012-10-24T14:18:54Z","timestamp":1351088334000},"page":"252-258","source":"Crossref","is-referenced-by-count":44,"title":["Worse glycaemic control in LADA patients than in those with type 2 diabetes, despite a longer time on insulin therapy"],"prefix":"10.1007","volume":"56","author":[{"given":"C. D.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bennet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Nystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Lindblad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Groop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Rolandsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,10,25]]},"reference":[{"key":"2759_CR1","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2337\/diabetes.48.1.150","volume":"48","author":"T Tuomi","year":"1999","unstructured":"Tuomi T, Carlsson A, Li H et al (1999) Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes 48:150\u2013157","journal-title":"Diabetes"},{"key":"2759_CR2","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00125-005-1690-x","volume":"48","author":"TM Davis","year":"2005","unstructured":"Davis TM, Wright AD, Mehta ZM et al (2005) Islet autoantibodies in clinically diagnosed type 2 diabetes: prevalence and relationship with metabolic control (UKPDS 70). Diabetologia 48:695\u2013702","journal-title":"Diabetologia"},{"key":"2759_CR3","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1007\/s00125-008-1161-2","volume":"51","author":"E Bakhtadze","year":"2008","unstructured":"Bakhtadze E, Cervin C, Lindholm E et al (2008) Common variants in the TCF7L2 gene help to differentiate autoimmune from non-autoimmune diabetes in young (15\u201334\u00a0years) but not in middle-aged (40\u201359\u00a0years) diabetic patients. Diabetologia 51:2224\u20132232","journal-title":"Diabetologia"},{"key":"2759_CR4","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s00125-007-0745-6","volume":"50","author":"M Desai","year":"2007","unstructured":"Desai M, Cull CA, Horton VA et al (2007) GAD autoantibodies and epitope reactivities persist after diagnosis in latent autoimmune diabetes in adults but do not predict disease progression: UKPDS 77. Diabetologia 50:2052\u20132060","journal-title":"Diabetologia"},{"key":"2759_CR5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.diabres.2008.07.022","volume":"82","author":"M Thunander","year":"2008","unstructured":"Thunander M, Petersson C, Jonzon K et al (2008) Incidence of type 1 and type 2 diabetes in adults and children in Kronoberg, Sweden. Diabetes Res Clin Pract 82:247\u2013255","journal-title":"Diabetes Res Clin Pract"},{"key":"2759_CR6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2337\/diabetes.45.5.622","volume":"45","author":"T Kobayashi","year":"1996","unstructured":"Kobayashi T, Nakanishi K, Murase T, Kosaka K (1996) Small doses of subcutaneous insulin as a strategy for preventing slowly progressive beta-cell failure in islet cell antibody-positive patients with clinical features of NIDDM. Diabetes 45:622\u2013626","journal-title":"Diabetes"},{"key":"2759_CR7","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1210\/jc.2007-2267","volume":"93","author":"T Maruyama","year":"2008","unstructured":"Maruyama T, Tanaka S, Shimada A et al (2008) Insulin intervention in slowly progressive insulin-dependent (type 1) diabetes mellitus. J Clin Endocrinol Metab 93:2115\u20132121","journal-title":"J Clin Endocrinol Metab"},{"key":"2759_CR8","first-page":"3","volume":"22","author":"M Norberg","year":"2010","unstructured":"Norberg M, Wall S, Boman K, Weinehall L (2010) The Vasterbotten Intervention Programme: background, design and implications. Glob Health Action Mar 22:3","journal-title":"Glob Health Action Mar"},{"key":"2759_CR9","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3109\/02813432.2012.675565","volume":"30","author":"O Rolandsson","year":"2012","unstructured":"Rolandsson O, Norberg M, Nystrom L et al (2012) How to diagnose and classify diabetes in primary health care: lessons learned from the Diabetes Register in Northern Sweden (DiabNorth). Scand J Prim Health Care 30:81\u201387","journal-title":"Scand J Prim Health Care"},{"key":"2759_CR10","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","volume":"15","author":"KG Alberti","year":"1998","unstructured":"Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15:539\u2013553","journal-title":"Diabet Med"},{"key":"2759_CR11","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1007\/s00125-005-1960-7","volume":"48","author":"S Fourlanos","year":"2005","unstructured":"Fourlanos S, Dotta F, Greenbaum CJ et al (2005) Latent autoimmune diabetes in adults (LADA) should be less latent. Diabetologia 48:2206\u20132212","journal-title":"Diabetologia"},{"key":"2759_CR12","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2337\/dc07-1308","volume":"31","author":"S Brophy","year":"2008","unstructured":"Brophy S, Yderstraede K, Mauricio D et al (2008) Time to insulin initiation cannot be used in defining latent autoimmune diabetes in adults. Diabetes Care 31:439\u2013441","journal-title":"Diabetes Care"},{"key":"2759_CR13","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","volume":"55","author":"SE Inzucchi","year":"2012","unstructured":"Inzucchi SE, Bergenstal RM, Buse JB et al (2012) Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetologia 55:1577\u20131596","journal-title":"Diabetologia"},{"key":"2759_CR14","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/dmrr.420","volume":"20","author":"E Lindholm","year":"2004","unstructured":"Lindholm E, Hallengren B, Agardh CD (2004) Gender differences in GAD antibody-positive diabetes mellitus in relation to age at onset, C-peptide and other endocrine autoimmune diseases. Diabetes Metab Res Rev 20:158\u2013164","journal-title":"Diabetes Metab Res Rev"},{"key":"2759_CR15","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2337\/db09-0747","volume":"59","author":"VM Lundgren","year":"2010","unstructured":"Lundgren VM, Isomaa B, Lyssenko V et al (2010) GAD antibody positivity predicts type 2 diabetes in an adult population. Diabetes 59:416\u2013422","journal-title":"Diabetes"},{"key":"2759_CR16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0022-1759(95)00139-2","volume":"186","author":"A Falorni","year":"1995","unstructured":"Falorni A, Ortqvist E, Persson B, Lernmark A (1995) Radioimmunoassays for glutamic acid decarboxylase (GAD65) and GAD65 autoantibodies using 35S or 3H recombinant human ligands. J Immunol Methods 186:89\u201399","journal-title":"J Immunol Methods"},{"key":"2759_CR17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF00408469","volume":"37","author":"CE Grubin","year":"1994","unstructured":"Grubin CE, Daniels T, Toivola B et al (1994) A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 37:344\u2013350","journal-title":"Diabetologia"},{"key":"2759_CR18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08916930802208540","volume":"42","author":"B Daka","year":"2009","unstructured":"Daka B, Svensson MK, Lernmark \u00c5, Mincheva-Nilsson L, Hallmans G, Rolandsson O (2009) Low agreement between radio binding assays in analyzing glutamic acid decarboxylase (GAD65Ab) autoantibodies in patients classified with type 2 diabetes. Autoimmunity 42:1\u20138","journal-title":"Autoimmunity"},{"key":"2759_CR19","doi-asserted-by":"crossref","unstructured":"Brophy S, Brunt H, Davies H, Mannan S, Williams R (2007) Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database Syst Rev Art no.: CD006165. DOI: 10.1002\/14651858.CD006165.pub2","DOI":"10.1002\/14651858.CD006165.pub2"},{"key":"2759_CR20","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1210\/jc.86.7.3032","volume":"86","author":"H Borg","year":"2001","unstructured":"Borg H, Gottsater A, Landin-Olsson M, Fernlund P, Sundkvist G (2001) High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age. J Clin Endocrinol Metab 86:3032\u20133038","journal-title":"J Clin Endocrinol Metab"},{"key":"2759_CR21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.2337\/dc06-1696","volume":"30","author":"R Buzzetti","year":"2007","unstructured":"Buzzetti R, Di Pietro S, Giaccari A et al (2007) High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes. Diabetes Care 30:932\u2013938","journal-title":"Diabetes Care"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2759-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-012-2759-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-012-2759-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T11:49:44Z","timestamp":1558612184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-012-2759-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10,25]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,2]]}},"alternative-id":["2759"],"URL":"https:\/\/doi.org\/10.1007\/s00125-012-2759-y","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,25]]}}}